222 related articles for article (PubMed ID: 15823830)
1. The effect of relcovaptan (SR 49059), an orally active vasopressin V1a receptor antagonist, on uterine contractions in preterm labor.
Steinwall M; Bossmar T; Brouard R; Laudanski T; Olofsson P; Urban R; Wolff K; Le-Fur G; Akerlund M
Gynecol Endocrinol; 2005 Feb; 20(2):104-9. PubMed ID: 15823830
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of SR 49059 on oxytocin-and vasopressin-induced uterine contractions in non-pregnant women.
Steinwall M; Bossmar T; Gaud C; Akerlund M
Acta Obstet Gynecol Scand; 2004 Jan; 83(1):12-8. PubMed ID: 14678081
[TBL] [Abstract][Full Text] [Related]
3. [Tocolysis with the beta-adrenomimetic Partusisten in premature labor].
Ivanov S
Akush Ginekol (Sofiia); 1997; 36(2):9-10. PubMed ID: 9471910
[TBL] [Abstract][Full Text] [Related]
4. Effects of SR 49059, an orally active V1a vasopressin receptor antagonist, on vasopressin-induced uterine contractions.
Bossmar T; Brouard R; Döberl A; Akerlund M
Br J Obstet Gynaecol; 1997 Apr; 104(4):471-7. PubMed ID: 9141585
[TBL] [Abstract][Full Text] [Related]
5. Tocolytic effects of intravenous nitroglycerin.
de Spirlet M; Treluyer JM; Chevret S; Rey E; Tournaire M; Cabrol D; Pons G
Fundam Clin Pharmacol; 2004 Apr; 18(2):207-13. PubMed ID: 15066136
[TBL] [Abstract][Full Text] [Related]
6. SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor.
Serradeil-Le Gal C; Valette G; Foulon L; Germain G; Advenier C; Naline E; Bardou M; Martinolle JP; Pouzet B; Raufaste D; Garcia C; Double-Cazanave E; Pauly M; Pascal M; Barbier A; Scatton B; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 2004 Apr; 309(1):414-24. PubMed ID: 14722330
[TBL] [Abstract][Full Text] [Related]
7. Relationship between uterine contractions and serum magnesium levels in patients treated for threatened preterm labour with intravenous magnesium sulphate.
Lurie S; Gur D; Sadan O; Glezerman M
J Obstet Gynaecol; 2004 Apr; 24(3):247-8. PubMed ID: 15203617
[TBL] [Abstract][Full Text] [Related]
8. [Tocolytic treatment of pregnant women with threatened abortions and preterm labor in the second and third trimesters of pregnancy with magne B6 (a preliminary communication)].
Marinov B; Damianov L; Tsache K; Atanasova B
Akush Ginekol (Sofiia); 1999; 38(1):74-6. PubMed ID: 11965731
[TBL] [Abstract][Full Text] [Related]
9. A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model.
Cenksoy C; Cenksoy PO; Erdem O; Sancak B; Gursoy R
Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():86-90. PubMed ID: 24405730
[TBL] [Abstract][Full Text] [Related]
10. Uterine contraction frequency before and after successful tocolytic therapy for preterm uterine contractions.
Newman RB; Johnson F; Das A; Goldenberg RL; Swain M; Moawad A; Sibai BM; Caritis SN; Miodovnik M; Paul RH; Dombrowski MP; Collins Sharp BA; Fischer M
J Reprod Med; 2003 Nov; 48(11):843-9. PubMed ID: 14686015
[TBL] [Abstract][Full Text] [Related]
11. Uterine activity after oral mifepristone administration in human pregnancies beyond 41 weeks' gestation.
Fassett MJ; Wing DA
Gynecol Obstet Invest; 2008; 65(2):112-5. PubMed ID: 17912003
[TBL] [Abstract][Full Text] [Related]
12. Relationship of measured external tocodynamometry with measured internal uterine activity.
Paul MJ; Smeltzer JS
Am J Perinatol; 1991 Nov; 8(6):417-20. PubMed ID: 1814307
[TBL] [Abstract][Full Text] [Related]
13. Oxytocin receptor blockade: a new principle in the treatment of preterm labor?
Andersen LF; Lyndrup J; Akerlund M; Melin P
Am J Perinatol; 1989 Apr; 6(2):196-9. PubMed ID: 2540760
[TBL] [Abstract][Full Text] [Related]
14. Tocolytic effect of a selective FP receptor antagonist in rodent models reveals an innovative approach to the treatment of preterm labor.
Chollet A; Tos EG; Cirillo R
BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S16. PubMed ID: 17570160
[TBL] [Abstract][Full Text] [Related]
15. Barusiban suppresses oxytocin-induced preterm labour in non-human primates.
Reinheimer TM
BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S15. PubMed ID: 17570159
[TBL] [Abstract][Full Text] [Related]
16. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
Richter ON; Dorn C; van de Vondel P; Ulrich U; Schmolling J
Arch Gynecol Obstet; 2005 Jun; 272(1):26-30. PubMed ID: 15909190
[TBL] [Abstract][Full Text] [Related]
17. Clinical practice evaluation of combination of atosiban, ritodrine and ketoprofen for inhibiting preterm labor.
Grignaffini A; Soncini E; Ronzoni E; Lo Cane F; Anfuso S; Nardelli GB
Minerva Ginecol; 2007 Oct; 59(5):481-9. PubMed ID: 17912174
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of oral nifedipine versus terbutaline injection in preterm labor.
Laohapojanart N; Soorapan S; Wacharaprechanont T; Ratanajamit C
J Med Assoc Thai; 2007 Nov; 90(11):2461-9. PubMed ID: 18181335
[TBL] [Abstract][Full Text] [Related]
19. Low-dose ethanol for inhibition of preterm uterine activity.
Schröck A; Fidi C; Löw M; Baumgarten K
Am J Perinatol; 1989 Apr; 6(2):191-5. PubMed ID: 2712916
[TBL] [Abstract][Full Text] [Related]
20. The effect of corticosteroid administration on uterine activity and preterm labor in high-order multiple gestations.
Elliott JP; Radin TG
Obstet Gynecol; 1995 Feb; 85(2):250-4. PubMed ID: 7824240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
